noscript

News and Announcements

Biorithm selected for MedTech Innovator Asia Pacific Accelerator cohort 2021

  • Published July 12, 2021 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Biorithm is thrilled to announce that our company has been selected to be part of the 2021 MedTech Innovator Asia Pacific Cohort.

Register Interest

MedTech Innovator is a medical technology global showcase and accelerator for innovative medical devices, digital health, and diagnostic companies. Every year, MedTech Innovator selects the most outstanding 20 medical technology startups across Asia Pacific region to participate in this program with the aim to help them grow and transform the healthcare system.

Through this program, Biorithm is expecting to have access to personalized mentorship and coaching to help with the commercialization of the Femom solution, visibility to healthcare investors, and broad exposure to leading players in the medical technology space.

Participants will also benefit from customised virtual curriculum and have access to webinar sessions from a parallel US program providing information regarding accessing and operating in the US and EU regions, which are part of the market targeted by Biorithm. In addition, the MedTech Innovator Asia Pacific Cohort startups will compete for up to US $300,000 in cash and awards.

About Biorithm

Founded by doctors and engineers, Biorithm is a medical technology start-up spun-off from Nanyang Technological University in Singapore. We believe that comprehensive maternal healthcare should leverage the power of digital health and advanced sensors to address individual patient and clinicians needs, enhance data-driven decisions, and complication prevention, and provide access to affordable and preventive care.

Biorithm has developed Femom, a cutting-edge analytic software together with medical-grade abdominal ECG wearable designed for remote monitoring of maternal and fetal physiological parameters. Our Femom solution enables clinicians to gain new insights into the health of the mother and baby whilst offering expecting mothers better access to healthcare, convenience, and more information about their pregnancy to identify early signs of complications.

Femom has been designed and developed in close collaboration with women, clinicians, and university hospitals.

 

Register Interest

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now